Clostridium difficile (C.diff) is a gram positive-spore forming anaerobic bacteria that forms colitis through the disruption of the gut flora after the consumption of antibiotics. The infection is associated with high morbidity and mortality. In order to reduce the incidence of C.diff the health board suggested the reduction of 4C antibiotics, however not in every case it is possible to avoid the antibiotic prescription.
|Number of pages||1|
|Publication status||Published - 21 May 2018|
|Event|| Farr PhD Symposium and Innovation Workshop - The Studio, Manchester, United Kingdom|
Duration: 21 May 2018 → 22 May 2018
|Workshop||Farr PhD Symposium and Innovation Workshop|
|Period||21/05/18 → 22/05/18|
- clostridium difficile
- risk prediction
- risk management
Joseph, A. A. (2018). Implementation of a risk predictive tool for Clostridium difficile in primary care. Poster session presented at Farr PhD Symposium and Innovation Workshop, Manchester, United Kingdom.